Evidence map›Paper›PMID 30792211›Full record

ArticleHaematologica2019

Fatal dysfunction and disintegration of thrombin-stimulated platelets.

Oleg V Kim, Tatiana A Nevzorova, Elmira R Mordakhanova, Anastasia A Ponomareva, Izabella A Andrianova, Giang Le Minh, Amina G Daminova, Alina D Peshkova, Mark S Alber, Olga Vagin and 2 more

Abstract read
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Oleg V KimUniversity of Pennsylvania Perelman School of Medicine, Department of Cell and Developmental Biology, Philadelphia, PA, USA.
Tatiana A NevzorovaKazan Federal University, Institute of Fundamental Medicine and Biology, Kazan, Russian Federation.
Elmira R MordakhanovaKazan Federal University, Institute of Fundamental Medicine and Biology, Kazan, Russian Federation.
Anastasia A PonomarevaKazan Federal University, Institute of Fundamental Medicine and Biology, Kazan, Russian Federation.
Izabella A AndrianovaKazan Federal University, Institute of Fundamental Medicine and Biology, Kazan, Russian Federation.
Giang Le MinhKazan Federal University, Institute of Fundamental Medicine and Biology, Kazan, Russian Federation.
Amina G DaminovaKazan Federal University, Institute of Fundamental Medicine and Biology, Kazan, Russian Federation.
Alina D PeshkovaKazan Federal University, Institute of Fundamental Medicine and Biology, Kazan, Russian Federation.
Mark S AlberUniversity of California Riverside, Department of Mathematics, Riverside, CA, USA.
Olga VaginGeffen School of Medicine at UCLA, Department of Physiology, Los Angeles, CA, USA.
Rustem I LitvinovUniversity of Pennsylvania Perelman School of Medicine, Department of Cell and Developmental Biology, Philadelphia, PA, USA.
John W WeiselUniversity of Pennsylvania Perelman School of Medicine, Department of Cell and Developmental Biology, Philadelphia, PA, USA weisel@pennmedicine.upenn.edu.

Funding

Multiscale modeling and empirical study of a mechanism limiting blood clot growthU01HL116330 · NHLBI · UNIVERSITY OF NOTRE DAME · PI ALBER, MARK · 2014 to 2018
$3.5M
Experiment-based multi-scale modeling of the tensile and compressive deformations of fibrinR01HL135254 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PUROHIT, PRASHANT KISHORE · 2017 to 2020
$1.6M
NHLBI NIH HHS R01 HL135254NHLBI NIH HHS U01 HL116330
6 · The paper itself

Abstract

Platelets play a key role in the formation of hemostatic clots and obstructive thrombi as well as in other biological processes. In response to physiological stimulants, including thrombin, platelets change shape, express adhesive molecules, aggregate, and secrete bioactive substances, but their subsequent fate is largely unknown. Here we examined late-stage structural, metabolic, and functional consequences of thrombin-induced platelet activation. Using a combination of confocal microscopy, scanning and transmission electron microscopy, flow cytometry, biochemical and biomechanical measurements, we showed that thrombin-induced activation is followed by time-dependent platelet dysfunction and disintegration. After ~30 minutes of incubation with thrombin, unlike with collagen or ADP, human platelets disintegrated into cellular fragments containing organelles, such as mitochondria, glycogen granules, and vacuoles. This platelet fragmentation was preceded by Ca

Indexed as

Cell DeathAdenosine DiphosphateAdenosine TriphosphateBlood CoagulationBlood PlateletsCalciumCollagenCytoskeletonFlow CytometryHumansMicroscopy, ConfocalMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionPlatelet ActivationPlatelet AggregationPlatelet-Rich PlasmaAdenosine DiphosphateAdenosine TriphosphateCalciumCollagenReactive Oxygen SpeciesThrombin

Identifiers

PMID30792211
PMCPMC6717590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.